ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect after a Drug Repurposing Screen
This article has 17 authors:Reviewed by ScreenIT
-
Deep Sentiment Classification and Topic Discovery on Novel Coronavirus or COVID-19 Online Discussions: NLP Using LSTM Recurrent Neural Network Approach
This article has 4 authors:Reviewed by ScreenIT
-
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance
This article has 18 authors:Reviewed by ScreenIT
-
ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study
This article has 6 authors:Reviewed by ScreenIT
-
Treating Influenza and SARS-CoV-2 via mRNA-encoded Cas13a
This article has 15 authors:Reviewed by ScreenIT
-
Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes revealed its epidemic trend and possible origins
This article has 10 authors:Reviewed by ScreenIT
-
Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells
This article has 9 authors:Reviewed by ScreenIT
-
Introductions and early spread of SARS-CoV-2 in France
This article has 14 authors:Reviewed by ScreenIT
-
Distinguishing Coronavirus Disease 2019 Patients From General Surgery Emergency Patients With the CIAAD Scale: Development and Validation of a Prediction Model Based on 822 Cases in China
This article has 10 authors:Reviewed by ScreenIT
-
The anticoagulant nafamostat potently inhibits SARS-CoV-2 infection in vitro : an existing drug with multiple possible therapeutic effects
This article has 14 authors:Reviewed by ScreenIT